Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating JY09 versus placebo in Type 2 Diabetes Mellitus is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JY09

Snippet

Sponsor: Beijing Dongfang Biotech Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: ACTIVE_NOT_RECRUITING